Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allocetra in Osteoarthritis of the 1st Carpo-metacarpal Joint
NCT06459063Phase 2Active, not recruiting
- Sponsor
- Kaplan Medical Center
- Start
- Jun 2024
- Primary completion
- Sep 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Allocetra in osteoarthritis (OA), sponsored by Kaplan Medical Center. Started Jun 2024; status: active, not recruiting.
02
Drugs
Allocetra
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06459063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06459063.